These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6681128)

  • 1. A study of platelet aggregation and adhesion in gout.
    Macfarlane DG; Slade R; Hopes PA; Hartog MH
    Clin Exp Rheumatol; 1983; 1(1):63-6. PubMed ID: 6681128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid levels and platelet function in humans. An in-vivo ex-vivo study.
    Ciompi ML; De Caterina R; Bertolucci D; Bernini W; Michelassi C; L'Abbate A
    Clin Exp Rheumatol; 1983; 1(2):143-7. PubMed ID: 6085297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of long-term base therapy on the clinical picture of gout].
    Baiatova KV
    Ter Arkh; 1981; 53(2):87-91. PubMed ID: 7221944
    [No Abstract]   [Full Text] [Related]  

  • 4. Gout resistant to allopurinol: poor compliance or non-response.
    Simmonds HA; Gibson T; Huston GJ; Webster DR; Rodgers AV; Munro J
    Adv Exp Med Biol; 1984; 165 Pt A():171-4. PubMed ID: 6720374
    [No Abstract]   [Full Text] [Related]  

  • 5. Disease-specific noncompliance with drug treatment as a cause of persistent hyperuricemia and gout in anorexia nervosa.
    Gröbner W; Walter-Sack I; de Vries JX
    Eur J Med Res; 1998 Feb; 3(1-2):77-80. PubMed ID: 9512972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of hyperuricemia with allopurinol].
    Hood B; Olander R; Sjöberg KH; Orndahl G
    Lakartidningen; 1968 Feb; 65(6):574-82. PubMed ID: 5723559
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with allopurinol decreases the number of acute gout attacks despite persistently elevated serum uric acid levels.
    Beutler AM; Rull M; Schlesinger N; Baker DG; Hoffman BI; Schumacher HR
    Clin Exp Rheumatol; 2001; 19(5):595. PubMed ID: 11579724
    [No Abstract]   [Full Text] [Related]  

  • 8. Azapropazone or allopurinol in the treatment of chronic gout and/or hyperuricaemia. A preliminary report.
    Templeton JS
    Br J Clin Pract; 1982 Oct; 36(10):353-8. PubMed ID: 7171423
    [No Abstract]   [Full Text] [Related]  

  • 9. Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.
    Stamp LK; Turner R; Khalilova IS; Zhang M; Drake J; Forbes LV; Kettle AJ
    Rheumatology (Oxford); 2014 Nov; 53(11):1958-65. PubMed ID: 24899662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E; Schwarczmann P
    Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allopurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A; Nardini A; Busonera G
    Clin Ter; 1968 Apr; 45(2):141-54. PubMed ID: 5736585
    [No Abstract]   [Full Text] [Related]  

  • 13. [Allopurinol in the treatment of gout].
    Isomäki H; Kemilä S
    Duodecim; 1968; 84(17):975-80. PubMed ID: 5704850
    [No Abstract]   [Full Text] [Related]  

  • 14. Allopurinol in treatment of patients with gout and chronic renal failure.
    Bowie EA; Simmonds HA; North JD
    N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
    [No Abstract]   [Full Text] [Related]  

  • 15. [Allopurinol in the treatment of gout. Preliminary report].
    Lignière GC; Cirla E
    Reumatismo; 1968; 20(2):101-3. PubMed ID: 5748155
    [No Abstract]   [Full Text] [Related]  

  • 16. [Allopurinol in the treatment of gout].
    Sabah D
    Rev Med Chil; 1970; 98(9):622-7. PubMed ID: 5509800
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricaemia.
    Fraser RC; Davis RH; Walker FS
    J R Coll Gen Pract; 1987 Sep; 37(302):409-11. PubMed ID: 3330140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allopurinol in the treatment of gout].
    Klein G; Griendl W; Kalb R
    Z Rheumaforsch; 1968 Dec; 27(11):455-60. PubMed ID: 5710881
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of allopurinol on plasma lipid fractions in gout patients].
    Giovannelli G; Carcassi A; Gragnoli G; Marcolongo R; Pupillo A
    Atti Accad Fisiocrit Siena Med Fis; 1967; 16(2):1011-24. PubMed ID: 5621168
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.